Literature DB >> 23329762

A case of complete androgen insensitivity syndrome with a novel androgen receptor mutation.

Vivian L Chin1, Sharone Sheffer-Babila, Ting A Lee, Kathryn Tanaka, Ping Zhou.   

Abstract

We report a case of a 14-year-old girl with primary amenorrhea and phenotypic as well as hormonal features of complete androgen insensitivity syndrome (CAIS), who tested positive for a novel missense androgen receptor gene mutation resulting in serine-to-isoleucine change at position 703 in exon 4 in the ligand-binding domain. The interesting features of this case include a persistence of Müllerian derivatives, Sertoli cell adenoma, Tanner III pubic hair, and a normal bone mineral density. These features are not typically described in CAIS. This novel mutation associated with a unique clinical presentation serves to significantly enrich the literature on this rare and fascinating disorder of androgen insensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23329762     DOI: 10.1515/jpem-2012-0135

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Phenotypic and molecular characteristics of androgen insensitivity syndrome patients.

Authors:  Shi-Min Yuan; Ya-Nan Zhang; Juan Du; Wen Li; Chao-Feng Tu; Lan-Lan Meng; Ge Lin; Guang-Xiu Lu; Yue-Qiu Tan
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

Review 2.  Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.

Authors:  Jia-Feng Chen; Pei-Wen Lin; Yi-Ru Tsai; Yi-Chien Yang; Hong-Yo Kang
Journal:  Cells       Date:  2019-10-25       Impact factor: 6.600

3.  Case Report: Low Bone and Normal Lean Mass in Adolescents With Complete Androgen Insensitivity Syndrome.

Authors:  Aaron Misakian; Michelle McLoughlin; Louisa C Pyle; Thomas F Kolon; Andrea Kelly; Maria G Vogiatzi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-30       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.